top of page

BackTable / Urology / Podcast / Episode #193

Bladder Cancer Innovations: ESMO 2024 Highlights

with Dr. Andrea Apolo

Catch up on the latest breakthroughs in bladder cancer management. In this episode of the BackTable Urology Podcast, Dr. Bogdana Schmidt (University of Utah) speaks with Dr. Andrea Apolo, a medical oncologist at the National Cancer Institute, about recent advancements in bladder cancer treatment presented at the 2024 European Society of Medical Oncology (ESMO) Congress.

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo on the BackTable Urology Podcast)
Ep 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
00:00 / 01:04

BackTable, LLC (Producer). (2024, October 8). Ep. 193 – Bladder Cancer Innovations: ESMO 2024 Highlights [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Andrea Apolo discusses Bladder Cancer Innovations: ESMO 2024 Highlights on the BackTable 193 Podcast

Dr. Andrea Apolo

Dr. Andrea Apolo is a urologic oncologist with the National Cancer Institute in Bethesda, Maryland.

Dr. Bogdana Schmidt discusses Bladder Cancer Innovations: ESMO 2024 Highlights on the BackTable 193 Podcast

Dr. Bogdana Schmidt

Dr. Bogdana Schmidt, MD, MPH, is a urologic surgeon specializing in urologic oncology at the University of Utah in Salt Lake City, Utah.

Synopsis

They review pivotal trials like the NIAGARA and AMBASSADOR studies, the TAR-200 drug delivery system, the use of bladder-sparing treatment, and the role of ctDNA as a biomarker. Further, they detail the effectiveness of systemic therapies such as gemcitabine and pembrolizumab, the implications of perioperative immunotherapy, and the future role of antibody-drug conjugates. The conversation highlights the trend towards less invasive approaches while improving survival rates from bladder cancer.

Timestamps

00:00 - Introduction
03:49 - NIAGARA Trial
09:10 - Challenges in Bladder Cancer Treatment
18:56 - AMBASSADOR Trial
25:30 - Adjuvant Immunotherapy
29:30 - Exploring Biomarkers and ctDNA
36:34 - Surgery and Less Invasive Therapies
46:31 - Future Directions in Bladder Cancer Treatment

Resources

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Innovaciones en Urología Reconstructiva: Desde Detroit a Puerto Rico con Dr. Omar Soto on the BackTable Urology Podcast)
Suction Devices in Urology: Improving Stone Removal with Dr. Roger Sur on the BackTable Urology Podcast)
Biodesign Insights: Embracing Risk & Innovation with Dr. Christopher Kinsella on the BackTable Urology Podcast)
BackTable Resident Edition: Tips for Virtual & In-Person Urology Residency Interviews  with Dr. Mihir Shah, Dr. Lindsay Hampson, Dr. Gina Badalato, and Yash Shah on the BackTable Urology Podcast)
IRP Monitoring: Enhancing Patient Outcomes in Urology with Dr. Julie Riley on the BackTable Urology Podcast)
Perfecting Rectal Spacer Placement for Optimal Care with Dr. Neil Taunk on the BackTable Urology Podcast)

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page